172 related articles for article (PubMed ID: 37205188)
1. Identification of a seven-lncRNAs panel that serves as a prognosis predictor and contributes to the malignant progression of laryngeal squamous cell carcinoma.
Zheng X; Gao W; Zhang Z; Xue X; Mijiti M; Guo Q; Wusiman D; Wang K; Zeng X; Xue L; Guo Z; An C; Wu Y
Front Oncol; 2023; 13():1106249. PubMed ID: 37205188
[TBL] [Abstract][Full Text] [Related]
2. Construction and integrated analysis of crosstalking ceRNAs networks in laryngeal squamous cell carcinoma.
Liu Y; Ye F
PeerJ; 2019; 7():e7380. PubMed ID: 31367490
[TBL] [Abstract][Full Text] [Related]
3. A novel microRNA panel exhibited significant potential in evaluating the progression of laryngeal squamous cell carcinoma.
Zhang L; Zhang Z; Zheng X; Lu Y; Dai L; Li W; Liu H; Wen S; Xie Q; Zhang X; Wang P; Wu Y; Gao W
Noncoding RNA Res; 2023 Dec; 8(4):550-561. PubMed ID: 37602318
[TBL] [Abstract][Full Text] [Related]
4. Identifying prognostic lncRNAs based on a ceRNA regulatory network in laryngeal squamous cell carcinoma.
Shi Y; Yang D; Qin Y
BMC Cancer; 2021 Jun; 21(1):705. PubMed ID: 34130645
[TBL] [Abstract][Full Text] [Related]
5. Aberrant methylation-mediated downregulation of lncRNA SSTR5-AS1 promotes progression and metastasis of laryngeal squamous cell carcinoma.
Wang B; Zhao L; Chi W; Cao H; Cui W; Meng W
Epigenetics Chromatin; 2019 Jun; 12(1):35. PubMed ID: 31196171
[TBL] [Abstract][Full Text] [Related]
6. The Prognostic Signature and Potential Target Genes of Six Long Non-coding RNA in Laryngeal Squamous Cell Carcinoma.
Gong S; Xu M; Zhang Y; Shan Y; Zhang H
Front Genet; 2020; 11():413. PubMed ID: 32411183
[TBL] [Abstract][Full Text] [Related]
7. An immune-related lncRNA pairs signature to identify the prognosis and predict the immune landscape of laryngeal squamous cell carcinoma.
Qian L; Ni T; Fei B; Sun H; Ni H
BMC Cancer; 2022 May; 22(1):545. PubMed ID: 35568824
[TBL] [Abstract][Full Text] [Related]
8. Using RNA sequencing to identify a putative lncRNA-associated ceRNA network in laryngeal squamous cell carcinoma.
Lyu K; Li Y; Xu Y; Yue H; Wen Y; Liu T; Chen S; Liu Q; Yang W; Zhu X; Wang Z; Chai L; Wen W; Li C; Lei W
RNA Biol; 2020 Jul; 17(7):977-989. PubMed ID: 32174248
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA profiling in laryngeal squamous cell carcinoma and its clinical significance: potential biomarkers for LSCC.
Shen Z; Li Q; Deng H; Lu D; Song H; Guo J
PLoS One; 2014; 9(9):e108237. PubMed ID: 25243407
[TBL] [Abstract][Full Text] [Related]
10. LncRNA MNX1-AS1 Contributes to Laryngeal Squamous Cell Carcinoma Growth and Migration by Regulating mir-744-5p/bcl9/β-Catenin Axis.
Ma B; Ren G; Xu J; Yin C; Shi Y
Cell Transplant; 2021; 30():9636897211005682. PubMed ID: 33821684
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.
Kong X; Qi J; Yan Y; Chen L; Zhao Y; Fang Z; Fan J; Liu M; Liu Y
J Cell Biochem; 2019 Oct; 120(10):17963-17974. PubMed ID: 31127661
[TBL] [Abstract][Full Text] [Related]
12. Aberrant methylation‑mediated decrease of lncRNA HNF1A‑AS1 contributes to malignant progression of laryngeal squamous cell carcinoma via EMT.
Shi Y; Zhang Q; Xie M; Feng Y; Ma S; Yi C; Wang Z; Li Y; Liu X; Liu H; Yang H; Yan Y; Zhang Y; Ren X; Luo H
Oncol Rep; 2020 Dec; 44(6):2503-2516. PubMed ID: 33125127
[TBL] [Abstract][Full Text] [Related]
13. Construction and validation of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in laryngeal squamous cell carcinoma.
Wang X; Pan Y; Ou Y; Duan T; Zou Y; Zhou X
World J Surg Oncol; 2022 May; 20(1):164. PubMed ID: 35606755
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expressed long non-coding RNAs in laryngeal squamous-cell carcinoma.
Li H; Wang FL; Li W; Fei YH; Wang YT; Zhang JE; Bi HY; Zhang M
Am J Otolaryngol; 2019; 40(5):615-625. PubMed ID: 31128861
[TBL] [Abstract][Full Text] [Related]
15. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
[TBL] [Abstract][Full Text] [Related]
16. [Roles and mechanisms of m
Yan BR; Wang P; Li YS; Yang LK; Li QY; Kan X; Wang JT; Sun YN
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Dec; 57(12):1470-1478. PubMed ID: 36707952
[No Abstract] [Full Text] [Related]
17. Increased expression of lncRNA FTH1P3 predicts a poor prognosis and promotes aggressive phenotypes of laryngeal squamous cell carcinoma.
Yuan H; Jiang H; Wang Y; Dong Y
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31142627
[TBL] [Abstract][Full Text] [Related]
18. LncRNA MNX1-AS1 drives aggressive laryngeal squamous cell carcinoma progression and serves as a ceRNA to target FoxM1 by sponging microRNA-370.
Cui X; Yu H; Yu T; Xiao D; Wang X
Aging (Albany NY); 2021 Mar; 13(7):9900-9910. PubMed ID: 33882027
[TBL] [Abstract][Full Text] [Related]
19. Aberrant methylation-mediated downregulation of the LINC01554 gene accelerates the malignant progression and regulates the chemosensitivity of laryngeal squamous cell carcinoma.
Wang J; Meng W; Yang J; Cao H; Liu T; Yang C; Yu M; Wang B
J Physiol Pharmacol; 2022 Apr; 73(2):. PubMed ID: 35988928
[TBL] [Abstract][Full Text] [Related]
20. Identification of a progression-associated long non-coding RNA signature for predicting the prognosis of lung squamous cell carcinoma.
Wang Y; Yang F; Zhuang Y
Exp Ther Med; 2018 Feb; 15(2):1185-1192. PubMed ID: 29434705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
